Evidence map›Paper›PMID 32552692›Full record

ArticleHealth research policy and systems2020

Clinical practice guidelines in Brazil - developing a national programme.

Verônica Colpani, Sérgio Candido Kowalski, Airton Tetelbom Stein, Anna Maria Buehler, Daniel Zanetti, Gabriel Côrtes, Edison Vieira de Melo Junior, Jorgiany Emerick Ebeidalla, Natiela Beatriz de Oliveira, Renata Leborato Guerra and 4 more

Abstract readLetter
In one paragraph

Article in Health research policy and systems, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Verônica ColpaniResearch Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro Barcelos, 910, 3° andar, Porto Alegre, RS, 90035-001, Brazil. veronica.colpani@hmv.org.br.ORCID http://orcid.org/0000-0002-7908-4213
Sérgio Candido KowalskiDepartment of Internal Medicine, Division of Rheumatology, Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil.
Airton Tetelbom SteinGraduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA); Program in Health Technology Assessment, Grupo Hospitalar Conceição, Porto Alegre, RS, Brazil.
Anna Maria BuehlerHealth Technology Assessment Unit, Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil.
Daniel ZanettiDepartment of Management and Incorporation of Health Technology (DGITIS), Executive Secretariat, National Committee for Health Technology Incorporation (CONITEC); Secretariat of Science, Technology and Strategic Inputs (SCTIE); Brazilian Ministry of Health, Brasília, DF, Brazil.
Gabriel CôrtesCONITEC; Plenary member, Special Secretary of Indigenous Health (SESAI), Brazilian Ministry of Health, Brasília, DF, Brazil.
Edison Vieira de Melo JuniorDGITIS; Executive Secretariat, CONITEC; Secretariat of Science, SCTIE, Brazilian Ministry of Health, Brasília, DF, Brazil.
Jorgiany Emerick EbeidallaDGITIS; Executive Secretariat, CONITEC; Secretariat of Science, SCTIE, Brazilian Ministry of Health, Brasília, DF, Brazil.
Natiela Beatriz de OliveiraGeneral Coordination, Environmental Health Surveillance (CGVAM); Department of Environmental Health, Worker and Emergency Public Health Surveillance (DSASTE); Secretariat of Health Surveillance (SVS); Brazilian Ministry of Health, Brasília, DF, Brazil.
Renata Leborato GuerraHealth Technology Assessment Unit (NATS), National Institute of Cancer (INCA), Rio de Janeiro, RJ, Brazil.
Sarah Nascimento SilvaDGITIS; Executive Secretariat, CONITEC; Secretariat of Science, SCTIE, Brazilian Ministry of Health, Brasília, DF, Brazil.
Bruce B DuncanSchool of Medicine, Hospital de Clínicas de Porto Alegre (HCPA), Instituto de Avaliação de Tecnologia em Saúde (IATS), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Maicon FalavignaResearch Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro Barcelos, 910, 3° andar, Porto Alegre, RS, 90035-001, Brazil.
Holger Jens SchünemannDepartment of Health Research Methods, Evidence and Impact and of Medicine, McMaster GRADE Centre, McMaster University Health Sciences Centre, Hamilton, Canada.

Funding

Ministério da Saúde .
6 · The paper itself

Abstract

In Brazil, governmental and non-governmental organisations develop practice guidelines (PGs) in order to optimise patient care. Although important improvements have been made over the past years, many of these documents still lack transparency and methodological rigour. In order to conduct a critical analysis and define future steps in PG development in Brazil, we carried out a structured assessment of strengths, weaknesses, opportunities and threats (SWOT analysis) for the development of a national guideline programme. Participants consisted of academia, methodologists, medical societies and healthcare system representatives. In summary, the PG development process has improved in Brazil and current investments in methodological research and capacity-building are ongoing. Despite the centralised processes for public PGs, standardised procedures for their development are not well established and human resources are insufficient in number and capacity to develop the amount of trustworthy documents needed. Brazil's capacity could be strengthened and initial efforts have been made such as the adoption of standards proposed by world-renowned institutions in PG development and enhancement of the involvement of key stakeholders. Further steps involve the alignment between health technology assessment and PG processes for synergy and the development of a national network to promote the interaction between groups involved in the development of PGs. The lessons learned from this paper could be used to foster debate on guideline development, especially for countries facing similar threats on this topic.

Indexed as

Practice Guidelines as TopicProgram DevelopmentBrazilCapacity BuildingEvidence-Based MedicineBrazilclinical practiceevidence-based medicineguideline development

Identifiers

PMID32552692
PMCPMC7302389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.